Symptomatic and asymptomatic carotid artery plaque

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 10, 2011, Pages 1315-1330

  Mughal, Majid M ^a   Khan, Mohsin K ^b   Demarco, J Kevin ^c   Majid, Arshad ^d   Shamoun, Fadi ^e   Abela, George S ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Michigan State University   (United States)

^d HOPE HOSPITAL   (United Kingdom)

^e MAYO CLINIC   (United States)

Author keywords

Carotid atherosclerosis; Carotid endarterectomy; Diagnostic studies; Medical therapy; Stenting; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; CLOPIDOGREL; DIPYRIDAMOLE; GELATINASE A; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

BLOOD PRESSURE REGULATION; CARDIAC IMAGING; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL INFILTRATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; DOPPLER ECHOGRAPHY; HUMAN; INFLAMMATORY CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING; STROKE; SURFACE ULTRASOUND; TRANSIENT ISCHEMIC ATTACK;

ASYMPTOMATIC DISEASES; CAROTID STENOSIS; DIAGNOSTIC IMAGING; HUMANS; STROKE;

EID: 80053974064     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.120     Document Type: Review

References (90)

1. Lloyd-Jones D, Adams RJ, Brown TM et al. Executive summary: heart disease and stroke statistics: 2010 update: a report from the American Heart Association. Circulation 121(7), 948-954 (2010).
2. Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics: 2010 update: a report from the American Heart Association. Circulation 121(12), e46-e215 (2010).
3. Petty G, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 30(12), 2513-2516 (1999).
4. Mineva PP, Manchev IC, Hadjiev DI. Prevalence and outcome of asymptomatic carotid stenosis: a population-based ultrasonographic study. Eur. J. Neurol. 9(4), 383-388 (2002). (Pubitemid 35013894)
5. Risk of stroke in the distribution of an asymptomatic carotid artery. The European Carotid Surgery Trialists Collaborative Group. Lancet 345(8944), 209-212 (1995).
6. Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J. Am. Coll. Cardiol. 23(3), 809-813 (1994). (Pubitemid 24074965)
7. Schaar JA, Muller JE, Falk E et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur. Heart J. 25(12), 1077-1082 (2004).
8. Libby P. Inflammation in atherosclerosis. Nature 420(6917), 868-874 (2002). (Pubitemid 36019640)
9. Kobayashi K, Kishi M, Atsumi T et al. Circulating oxidized LDL forms complexes with b2-glycoprotein I: implication as an atherogenic autoantigen. J. Lipid Res. 44(4), 716-726 (2003). (Pubitemid 37279673)
10. Guyton JR, Klemp KF. Development of the lipid-rich core in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 16(1), 4-11 (1996). (Pubitemid 26026925)
11. Abela GS, Aziz K. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events: a novel insight into plaque rupture by scanning electron microscopy. Scanning 28(1), 1-10 (2006). (Pubitemid 43221678)
12. Abela GS, Aziz K, Vedre A, Pathak DR, Talbott JD, Dejong J. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am. J. Cardiol. 103(7), 959-968 (2009).
13. Vedre A, Pathak DR, Crimp M, Lum C, Koochesfahani M, Abela GS. Physical factors that trigger cholesterol crystallization leading to plaque rupture. Atherosclerosis 203(1), 89-96 (2009).
14. Gadeela N, Rubinstein J, Tamhane U et al. The impact of circulating cholesterol crystals on vasomotor function implications for no-reflow phenomenon. JACC Cardiovasc. Interv. 4(5), 521-529 (2011).
15. Stary HC. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler. Thromb. Vasc. Biol. 20(5), 1177-1178 (2000). (Pubitemid 30262913)
16. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15(9), 1512-1531 (1995).
17. Carr S, Farb A, Pearce WH, Virmani R, Yao JS. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J. Vasc. Surg. 23(5), 755-765 (1996).
18. Abela GS. Cholesterol crystals piercing the arterial plaque and intima triggers local and systemic inflammation. J. Clin. Lipidol. 4(3), 156-164 (2010).
19. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br. Heart J. 53(4), 363-373 (1985). (Pubitemid 15055510)
20. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ. Res. 71(4), 850-858 (1992).
21. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102(9), 959-964 (2000). (Pubitemid 30656003)
22. Abela GS, Vedre A, Janoudi A, Huang R, Durga S, Tamhane U. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am. J. Cardiol. 107(12), 1710-1717 (2011).
23. Ota H, Yu W, Underhill HR. Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler. Thromb. Vasc. Biol. 29(10), 1696-1701 (2009).
24. Underhill HR, Yuan C, Yarnykh VL et al. Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. AJNR Am. J. Neuroradiol. 31(3), 487-493 (2009).
25. Dickson BC, Gotlieb AI. Towards understanding acute destabilization of vulnerable atherosclerotic plaques. Cardiovasc. Pathol. 12(5), 237-248 (2003). (Pubitemid 37162706)
26. Frink RJ. Parallel cholesterol crystals: a sign of impending plaque rupture? J. Invasive Cardiol. 22(9), 406-411 (2010).
27. Carr SC, Farb A, Pearce WH, Virmani R, Yao JS. Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery 122(4), 757-763; discussion 763-764 (1997).
28. Jander S, Sitzer M, Schumann R et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 29(8), 1625-1630 (1998). (Pubitemid 28365585)
29. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94(6), 2493-2503 (1994). (Pubitemid 24379627)
30. Mach F, Sch1nbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/ macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96(2), 396-399 (1997). (Pubitemid 27329409)
31. Del Prete G, De Carli M, Lammel RM et al. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86(1), 250-257 (1995).
32. Dewell P, Kono H, Rayner KJ et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293), 1357-1361 (2010).
33. Ionita MG, van den Borne P, Catanzariti LM et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of ruptureprone lesions. Arterioscler. Thromb. Vasc. Biol. 30(9), 1842-1848 (2010).
34. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N. Engl. J. Med. 310(3), 175-177 (1984). (Pubitemid 14224112)
35. Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V. Neovascularization in human atherosclerosis. Curr. Mol. Med. 6(5), 457-477 (2006).
36. Abela GS, Maheshwari A, Kantipudi SC. Atherosclerotic vascular disease as a systemic process. In: Peripheral Vascular Disease: Diagnostic and Therapeutic Approaches. Abela GS (Ed.). Lippincott Williams & Wilkins, NY, USA, 23-36 (2004).
37. Altaf N, Goode SD, Beech A et al. Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease. Radiology 258(2), 538-545 (2011).
38. Kolodgie FD, Gold HK, Burke AP et al. Intraplaque hemorrhage and progression of coronary atheroma. N. Engl. J. Med. 349(24), 2316-2325 (2003). (Pubitemid 37509739)
39. Redgrave JN, Lovett JK, Rothwell PM. Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke 41(10), 2288-2294 (2010).
40. Ota H, Reeves MJ, Zhu DC et al. Sex differences in patients with asymptomatic carotid atherosclerotic plaque: in vivo 3.0-T magnetic resonance study. Stroke 41(8), 1630-1635 (2010).
41. Peeters W, Hellings WE, de Kleijn DP et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler. Thromb. Vasc. Biol. 29(1), 128-133 (2009).
42. Gompels BM. High definition imaging of carotid arteries using a standard commercial ultrasound 'B' scanner. A preliminary report. Br. J. Radiol. 52(620), 608-619 (1979). (Pubitemid 9239861)
43. Wolff, T, Guirguis-Blake J, Miller T, Gillespie, M, Harris R. Screening for carotid artery stenosis: an update of the evidence for the U. S. Preventive Services Task Force. Ann. Intern. Med. 147(12), 860-870 (2007). (Pubitemid 351664428)
44. Kuhn FP, Kramer G, Günther R, Thelen M. [B-scan sonography of the carotid artery. Technique, results and indications (author's translation)]. Rofo 135(4), 407-411 (1981). (Pubitemid 12070890)
45. Beletsky VY, Kelley RE, Fowler M, Phifer T. Ultrasound densitometric analysis of carotid plaque composition. Pathoanatomic correlation. Stroke 27(12), 2173-2177 (1996).
46. Srimek A, Bosch JG, Reiber JH, Van Oostayen JA, Rosendaal FR. Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries. Invest. Radiol. 35(12), 699-706 (2000). (Pubitemid 32039029)
47. Kathiresan S, Larson MG, Keyes MJ et al. Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am. J. Cardiol. 99(3), 310-314 (2007). (Pubitemid 46149547)
48. Nambi V, Chambless L, Folsom AR et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J. Am. Coll. Cardiol. 55(15), 1600-1607 (2010).
49. Cai J, Hatsukami TS, Ferguson MS et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrastenhanced magnetic resonance imaging and histology. Circulation 112(22), 3437-3444 (2005). (Pubitemid 43739559)
50. Ota H, Yarnykh VL, Ferguson MS et al. Carotid intraplaque hemorrhage imaging at 3.0-T MR imaging: comparison of the diagnostic performance of three T1- weighted sequences. Radiology 254(2), 551-563 (2011).
51. Saam T, Cai JM, Cai YQ et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler. Thromb. Vasc. Biol. 25(3), 234-239 (2005). (Pubitemid 40054282)
52. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 47(8 Suppl.), C13-C18 (2006).
53. Singh N, Moody AR, Gladstone DJ et al. Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 252(2), 502-508 (2009).
54. Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI: initial results. Stroke 37(3), 818-823 (2006). (Pubitemid 43731915)
55. Kurosaki Y, Yoshida K, Endo H, Chin M, Yamagata S. Association between carotid atherosclerosis plaque with high signal intensity on T1-weighted imaging and subsequent ipsilateral ischemic events. Neurosurgery 68(1), 62-67; discussion 67 (2011).
56. Underhill HR, Yuan C. Carotid MRI: a tool for monitoring individual response to cardiovascular therapy? Expert. Rev. Cardiovasc. Ther. 9(1), 63-80 (2011).
57. M0hlenbruch G, Das M, Mommertz G et al. Comparison of dual-source CT angiography and MR angiography in preoperative evaluation of intraand extracranial vessels: a pilot study. Eur. Radiol. 20(2), 469-476 (2009).
58. Josephson SA, Bryant SO, Mak HK, Johnston SC, Dillon WP, Smith WS. Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology 63(3), 457-460 (2004). (Pubitemid 39031374)
59. Silvennoinen HM, Ikonen S, Soinne L, Railo M, Valanne L. CT angiographic analysis of carotid artery stenosis: comparison of manual assessment, semiautomatic vessel analysis, and digital subtraction angiography. AJNR Am. J. Neuroradiol. 28(1), 97-103 (2007). (Pubitemid 46147543)
60. Anzola GP, Gasparotti R, Magoni M, Prandini F. Transcranial Doppler sonography and magnetic resonance angiography in the assessment of collateral hemispheric flow in patients with carotid artery disease. Stroke 26(2), 214-217 (1995).
61. Kaposzta Z, Young E, Bath PM, Markus HS. Clinical application of asymptomatic embolic signal detection in acute stroke: a prospective study. Stroke 30(9), 1814-1818 (1999). (Pubitemid 29411820)
62. Markus HS, King A, Shipley M et al. Asymptomatic embolization for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 9(7), 663-671 (2010).
63. Abela GS, Farooq MU, Berger K, Pathak D, Kassab M. A novel method of identifying unstable plaque by simultaneous carotid Ultrasound and trans-cranial doppler. J. Am. Coll. Cardiol. 55(10 Suppl. A), 161 (2010).
64. Aziz K, Berger K, Claycombe K, Huang R, Patel R, Abela GS. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation 117(16), 2061-2070 (2008). (Pubitemid 351572167)
65. Rudd JH, Warburton EA, Fryer TD et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105(23), 2708-2711 (2002). (Pubitemid 34615139)
66. Tawakol A, Migrino RQ, Hoffmann U et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J. Nucl. Cardiol. 12(3), 294-301 (2005). (Pubitemid 40790404)
67. Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis 213(1), 21-29 (2010).
68. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Eng. J. Med. 325(7), 445-453 (1991).
69. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273(18), 1421-1428 (1995).
70. Halliday A, Mansfield A, Marro J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363, 1491-1502 (2004).
71. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 40(10), e573-e583 (2009).
72. Jacobowitz GR, Rockman CB, Gagne PJ et al. A model for predicting occult carotid artery stenosis: screening is justified in a selected population. J. Vasc. Surg. 38(4), 705-709 (2003). (Pubitemid 37254795)
73. Davies KN, Humphrey PR. Do carotid bruits predict disease of the internal carotid arteries? Postgrad. Med. J. 70(824), 433-435 (1994). (Pubitemid 24196869)
74. Blauw GJ, Lagaay AM, Smelt AH, Westendorp RG. Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28(5), 946-950 (1997). (Pubitemid 27209138)
75. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364(9435), 685-696 (2004). (Pubitemid 39140624)
76. Sever PS, Dahlcf B, Poulter NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial: Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361(9364), 1149-1158 (2003). (Pubitemid 36398384)
77. Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360(9346), 1623-1630 (2002). (Pubitemid 35379733)
78. MacMahon S, Sharpe N, Gamble G et al. Effects of lowering average of belowaverage cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation 97(18), 1784-1790 (1998). (Pubitemid 28213621)
79. Amarenco P, Bogousslavsky J, Callahan A 3rd et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 355(6), 549-559 (2006). (Pubitemid 44202151)
80. Bhatt DL, Fox KA, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med. 354(16), 1706-1717 (2006).
81. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in highrisk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364(9431), 331-337 (2004).
82. Brott TG, Halperin JL, Abbara S et al. ASA/ACCF/AHA/AANN/AANS/ACR/ ASNR/CNS/SAIP/SCAI/SIR/SNIS/ SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 57(8), 1002-1044 (2011).
83. Nicolaides AN, Kakkos SK, Kyriacou et al. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J. Vasc. Surg. 52(6), 1486-1496.e1-5 (2010).
84. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 351(15), 1493-1501 (2004).
85. Brott TG, Hobson RW 2nd, Howard G et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N. Engl. J. Med. 363(1), 11-23 (2010).
86. Johnston SC, Rothwell PM, Nguyen- Huynh MN et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369(9558), 283-292 (2007). (Pubitemid 46136488)
87. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(1), 227-276 (2010).
88. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 34(11), 2741-2748 (2003). (Pubitemid 37392777)
89. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351(9113), 1379-1387 (1998).
90. Hobson RW 2nd, Weiss DG, Fields WS et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N. Engl. J. Med. 328(4), 221-227 (1993). (Pubitemid 23035306)